Business
GB Sciences Prepares To Launch New Products In Louisiana With Educational Seminars For Doctors And Pharmacists
GB Sciences Prepares To Launch New Products In Louisiana With Educational Seminars For Doctors And Pharmacists.
About this update from Gb Sciences, Inc.
[{"type":"text","content":"\n\n\n\nGB Sciences Prepares To Launch New Products In Louisiana With Educational Seminars For Doctors And Pharmacists\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nGB Sciences Prepares To Launch New Products In Louisiana With Educational Seminars For Doctors And Pharmacists\nPR Newswire\nLAS VEGAS, Aug. 7, 2019\n\n\n\nEducation program includes evidence-based review of FDA-registered human clinical trial data supporting the use of cannabis to treat approved medical conditions.\n LAS VEGAS, Aug. 7, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announced that its subsidiary GB Sciences Louisiana will hold a series of seminars in August, in partnership with state-approved medical cannabis pharmacies and the LSU AgCenter, to further educate Louisiana physicians and pharmacists about the new medical cannabis products that the company will launch in coming months. \n\n \n \n\n \nLouisiana's medical cannabis program encourages the active participation of both recommending physicians and pharmacists who interact with cannabis patients at the point of sale. This seminar series is focused on helping medical professionals prepare for these consultations. \nJohn Davis, President of GB Sciences Louisiana, said, \"Physicians and pharmacists will be prepared to counsel patients with up-to-date information on therapeutic cannabis. We want to help healthcare professionals understand the potency of our formulations, how to best recommend our products and the evidence-based approach that influenced and supports their design and use.\"\nDr. Andrea Small-Howard, Chief Science Officer and Director of GB Sciences, will present randomized, placebo-controlled, human clinical trial data to illustrate the safety and potential efficacy of medical cannabis-based therapies for approved medical conditions in Louisiana. The seminars also include a tutorial on the recommended usage and dosing of GB Sciences Louisiana's new medical cannabis products.\n\"We recommend that patients start with low doses of cannabis-based products and then gradually increase doses over time until they ach...